Difficulty: Medium
Average Score: 70%
Practice
The appropriate therapy of severe obstructive sleep apnea syndrome is
Correct answer
A
Rationale
In pediatric patients with severe obstructive sleep apnea syndrome, the appropriate therapy is often adenotonsillectomy (Option A). This procedure involves the removal of the adenoids and tonsils, which are common sites of obstruction in children with sleep apnea. Adenotonsillectomy is considered the first-line treatment for pediatric obstructive sleep apnea and has been shown to significantly improve symptoms and quality of life in affected children.
Tracheostomy (Option B) is a more invasive procedure typically reserved for cases of severe obstructive sleep apnea that do not respond to other treatments. It is not the first-line therapy for pediatric patients with sleep apnea due to the associated risks and long-term implications.
Parapharyngeal muscle surgery (Option C) is not a standard treatment for obstructive sleep apnea in children. This option is not commonly used and lacks sufficient evidence to support its effectiveness in improving sleep apnea symptoms.
Theophylline (Option D) is a medication that is sometimes used in the management of asthma or chronic obstructive pulmonary disease but is not considered appropriate for the treatment of obstructive sleep apnea syndrome in children.
In an educational context, understanding the appropriate treatment for pediatric obstructive sleep apnea is crucial for healthcare providers working with children. Adenotonsillectomy is a well-established and effective intervention for addressing obstructive sleep apnea in this population, and knowledge of this treatment option can help improve outcomes and quality of life for affected children. It is important for healthcare professionals to be aware of the various treatment modalities available for pediatric sleep apnea to provide optimal care and support for their patients.
Tracheostomy (Option B) is a more invasive procedure typically reserved for cases of severe obstructive sleep apnea that do not respond to other treatments. It is not the first-line therapy for pediatric patients with sleep apnea due to the associated risks and long-term implications.
Parapharyngeal muscle surgery (Option C) is not a standard treatment for obstructive sleep apnea in children. This option is not commonly used and lacks sufficient evidence to support its effectiveness in improving sleep apnea symptoms.
Theophylline (Option D) is a medication that is sometimes used in the management of asthma or chronic obstructive pulmonary disease but is not considered appropriate for the treatment of obstructive sleep apnea syndrome in children.
In an educational context, understanding the appropriate treatment for pediatric obstructive sleep apnea is crucial for healthcare providers working with children. Adenotonsillectomy is a well-established and effective intervention for addressing obstructive sleep apnea in this population, and knowledge of this treatment option can help improve outcomes and quality of life for affected children. It is important for healthcare professionals to be aware of the various treatment modalities available for pediatric sleep apnea to provide optimal care and support for their patients.